Desosamine in multicomponent reactions

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 24, 2006, Pages 6360-6362

  Achatz, Sepp ^a,b   Dömling, Alexander ^a,b  

^a ABC Pharma   (Germany)

^b Biovertis AG   (Germany)

Author keywords

Antibiotic; Desosamine; Isocyanide; Multicomponent reaction; Ribosome; Tetrazole

Indexed keywords

2 AMINODESOSAMINE; CYANIDE; ERYTHROMYCIN; NATURAL PRODUCT; UNCLASSIFIED DRUG;

AMINOLYSIS; ARTICLE; CHEMICAL REACTION; COMBINATORIAL CHEMISTRY; DRUG DESIGN; DRUG HYDROLYSIS; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROGEN BOND; STRUCTURE ANALYSIS;

AMINO SUGARS; ANTI-BACTERIAL AGENTS; CARBOHYDRATE CONFORMATION; DRUG DESIGN; MODELS, MOLECULAR;

EID: 33750712741     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.07.017     Document Type: Article

References (28)

1. Schlünzen F., Zarivach R., Harms J., Bashan A., Tocilj A., Albrecht R., Yonath A., and Franceschi F. Nature 413 (2001) 814
2. Hansen J., Ippolito J.A., Ban N., Nissen P., Moore P.B., and Seitz T.A. Mol. Cell 10 (2002) 117
3. Wilson D.N., Harms J.M., Nierhaus K.H., Schlünzen F., and Fucini P. Biol. Chem. 386 (2005) 1239
4. Dömling A. Nucleosides Nucleotides 17 (1998) 1667
5. Beck B., Dömling A., and Hess S. Bioorg. Med. Chem. Lett. 10 (2000) 1701
6. Beck B., Magnin-Lachaux M., Herdtweck E., and Dömling A. Org. Lett. 3 (2001) 2875
7. Henkel B., Sax M., and Dömling A. Tetrahedron Lett. 44 (2003) 7015
8. Henkel B., Sax M., and Dömling A. Tetrahedron Lett. 44 (2003) 3679
9. Henkel B., Westner B., Beck B., Mejat B., and Dömling A. Tetrahedron Lett. 44 (2003) 8947
10. Beck B., Picard A., Herdtweck E., and Dömling A. Org. Lett. 6 (2004) 39
11. Kusebauch U., Beck B., Messer K., Herdtweck E., and Dömling A. Org. Lett. 5 (2003) 4021
12. Kolb J., Beck B., Almstetter M., Heck S., Herdtweck E., and Dömling A. Mol. Div. 6 (2003) 297
13. Yehia N., Antuch W., Hess S., and Dömling A. Bioorg. Med. Chem. Lett. 14 (2004) 3121
14. Antuch W., Menon S., Chen Q.-Z., Lu Y., Sakamuri S., Beck B., Schauer-Vukašinović V., Agarwal S., Hess S., and Dömling A. Bioorg. Med. Chem. Lett. 6 (2006) 1740
15. Dömling A., Herdtweck E., and Heck S. Tetrahedron Lett. 47 (2005) 1745
16. Dömling A., and Ugi I. Angew. Chem., Int. Ed. 39 (2000) 3168
17. Bienaymé H., Hulme C., Oddon G., and Schmitt P. Chem. Eur. J. 6 (2000) 3321
18. Orru R.V.A., and de Greef M. Synthesis (2003) 1471
19. Hulme C., and Nixey T. Curr. Opin. Drug Discovery Dev. 6 (2003) 921
20. Dömling A. Chem. Rev. 126 (2006) 17
21. Wiley P.F. Methods Carbohydr. Chem. 1 (1962) 257
22. Dömling, A., unpublished.
23. Likhosherstov L.M., Novikova O.S., Derevitskaja V.A., and Kochetkov N.K. Carbohydr. Res. 146 (1986) C1-C5
24. Ugi I., and Steinbrückner C. Chem. Ber. 94 (1961) 734
25. Hulme C. In: Zhu J., and Bienaymé H. (Eds). Multicomponent Reactions (2004), Wiley 332
26. + = 436.4.
27. Antibacterial screening method: The screening method used was designed to be high throughput. The test strains (P. aeruginosa ATCC 9027, S. aureus ATCC 6538 and C. albicans ATCC 10231) were grown overnight (at 35 °C in CASO bouillon: bacteria; at 20 °C in Sabouraud bouillon: C. albicans). The suspension was centrifuged (5000 μl min, 40 °C) and the pellet was resuspended in fresh medium and incubated for another 2 h. The suspension was then transferred into a 96-well plate and incubated with compounds. The cps were tested at 400 μM. The DMSO content is 5%. In the first column of a 96-well plate a 5% DMSO solution without cps refers to 100% growth. The growth in the presence of cps was determined by measuring the optical density at 550 nm in a plate reader at three different times: 0, 24 and 48 h. The screening service was performed at Bioservice/Planegg/Germany.
28. Tang L., and McDaniel R. Chem. Biol. 8 (2001) 547